Atlas Trials

Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

Clinical trial NCT03322345 · TERMINATED

Trial details

NCT number
NCT03322345
Sponsor
University of Michigan
Status
TERMINATED
Study type
OBSERVATIONAL
DopamineProtein-Losing EnteropathiesLymphatic SystemLymphCatecholamineSingle-ventricleCongenital Heart Disease
Start date
2019-04-09
Primary completion
2025-05-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.